Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 37: 1534-1539, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackburn, G. F.
Right arrow Articles by Talley, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackburn, G. F.
Right arrow Articles by Talley, D. B.

Clinical Chemistry, Vol 37, 1534-1539, Copyright © 1991 by American Association for Clinical Chemistry

Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics

GF Blackburn, HP Shah, JH Kenten, J Leland, RA Kamin, J Link, J Peterman, MJ Powell, A Shah and DB Talley
IGEN, Inc., Rockville, MD 20852.

Electrochemiluminescence (ECL) has been developed as a highly sensitive process in which reactive species are generated from stable precursors (i.e., the ECL-active label) at the surface of an electrode. This new technology has many distinct advantages over other detection systems: no radioisotopes are used; detection limits for label are extremely low (200 fmol/L); the dynamic range for label quantification extends over six orders of magnitude; the labels are extremely stable compared with those of most other chemiluminescent systems; the labels, small molecules (approximately 1000 Da), can be used to label haptens or large molecules, and multiple labels can be coupled to proteins or oligonucleotides without affecting immunoreactivity, solubility, or ability to hybridize; because the chemiluminescence is initiated electrochemically, selectivity of bound and unbound fractions can be based on the ability of labeled species to access the electrode surface, so that both separation and nonseparation assays can be set up; and measurement is simple and rapid, requiring only a few seconds. We illustrate ECL in nonseparation immunoassays for digoxin and thyrotropin and in separation immunoassays for carcinoembryonic antigen and alpha-fetoprotein. The application of ECL for detection of polymerase chain reaction products is described and exemplified by quantifying the HIV1 gag gene.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Thaler, J. Metzger, A. Schreiegg, B. Denk, A. Gleixner, H. Hauptmann, and P. B. Luppa
Immunoassay for Sex Hormone-Binding Globulin in Undiluted Serum Is Influenced by High-Molecular-Mass Aggregates
Clin. Chem., February 1, 2005; 51(2): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K.C. A. Chan, L. C.W. Lit, E. L.K. Law, M. H.L. Tai, C.U. Yung, M. H.M. Chan, and C. W.K. Lam
Diminished Urinary Free Cortisol Excretion in Patients with Moderate and Severe Renal Impairment
Clin. Chem., April 1, 2004; 50(4): 757 - 759.
[Full Text] [PDF]


Home page
J Biomol ScreenHome page
R. Golla and R. Seethala
A Sensitive, Robust High-Throughput Electrochemiluminescence Assay for Rat Insulin
J Biomol Screen, February 1, 2004; 9(1): 62 - 70.
[Abstract] [PDF]


Home page
CVIHome page
A. H. Peruski and L. F. Peruski Jr.
Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents
Clin. Vaccine Immunol., July 1, 2003; 10(4): 506 - 513.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S.-J. L. Wu, E. M. Lee, R. Putvatana, R. N. Shurtliff, K. R. Porter, W. Suharyono, D. M. Watts, C.-C. King, G. S. Murphy, C. G. Hayes, et al.
Detection of Dengue Viral RNA Using a Nucleic Acid Sequence-Based Amplification Assay
J. Clin. Microbiol., August 1, 2001; 39(8): 2794 - 2798.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al.
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Blood, July 15, 2000; 96(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. W. Romano, S. Tetali, E. M. Lee, R. N. Shurtliff, X. P. Wang, S. Pahwa, M. H. Kaplan, and C. C. Ginocchio
Genotyping of the CCR5 Chemokine Receptor by Isothermal NASBA Amplification and Differential Probe Hybridization
Clin. Vaccine Immunol., November 1, 1999; 6(6): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. Yamaguchi, T. Sawada, T. Naraki, R. Igata-Yi, H. Shiraki, Y. Horii, T. Ishii, K. Ikeda, N. Asou, H. Okabe, et al.
Detection of Borna Disease Virus-Reactive Antibodies from Patients with Psychiatric Disorders and from Horses by Electrochemiluminescence Immunoassay
Clin. Vaccine Immunol., September 1, 1999; 6(5): 696 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. P. de Baar, A. M. van der Schoot, J. Goudsmit, F. Jacobs, R. Ehren, K. H. M. van der Horn, P. Oudshoorn, F. de Wolf, and A. de Ronde
Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target
J. Clin. Microbiol., June 1, 1999; 37(6): 1813 - 1818.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
C. D. O'Connell, A. Juhasz, C. Kuo, D. J. Reeder, and D. S. B. Hoon
Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence
Clin. Chem., June 1, 1998; 44(6): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y.-T. Ma, T. Hsieh, M. E. Forbes, J. E. Johnson, and D. O. Frost
BDNF Injected into the Superior Colliculus Reduces Developmental Retinal Ganglion Cell Death
J. Neurosci., March 15, 1998; 18(6): 2097 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Burks, G. Chen, G. Georgiou, and B. L. Iverson
In vitro scanning saturation mutagenesis of an antibody binding pocket
PNAS, January 21, 1997; 94(2): 412 - 417.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
E T Wilkinson, S Cheifetz, and S A De Grandis
Development of competitive PCR and the QPCR system 5000 as a transcription-based screen.
Genome Res., June 1, 1995; 4(6): 363 - 367.
[Abstract] [PDF]


Home page
Genome ResHome page
B van Gemen, P v d Wiel, R van Beuningen, P Sillekens, S Jurriaans, C Dries, R Schoones, and T Kievits
The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application.
Genome Res., February 1, 1995; 4(4): S177 - S184.
[PDF]


Home page
Genome ResHome page
J G Lazar
Advanced methods in PCR product detection.
Genome Res., August 1, 1994; 4(1): S1 - S14.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.